Mutation and Cancer: Statistical Study of Retinoblastoma
Overview
Authors
Affiliations
Based upon observations on 48 cases of retinoblastoma and published reports, the hypothesis is developed that retinoblastoma is a cancer caused by two mutational events. In the dominantly inherited form, one mutation is inherited via the germinal cells and the second occurs in somatic cells. In the nonhereditary form, both mutations occur in somatic cells. The second mutation produces an average of three retinoblastomas per individual inheriting the first mutation. Using Poisson statistics, one can calculate that this number (three) can explain the occasional gene carrier who gets no tumor, those who develop only unilateral tumors, and those who develop bilateral tumors, as well as explaining instances of multiple tumors in one eye. This value for the mean number of tumors occurring in genetic carriers may be used to estimate the mutation rate for each mutation. The germinal and somatic rates for the first, and the somatic rate for the second, mutation, are approximately equal. The germinal mutation may arise in some instances from a delayed mutation.
Laks S, Goldenshluger M, Lebedeyev A, Anderson Y, Gruper O, Segev L Cancers (Basel). 2025; 17(5).
PMID: 40075705 PMC: 11898783. DOI: 10.3390/cancers17050859.
Precision therapeutic targets for HPV-positive cancers: an overview and new insights.
Huang Y, Wang J, Yang W, Hou F, Feng X Infect Agent Cancer. 2025; 20(1):17.
PMID: 40069817 PMC: 11900425. DOI: 10.1186/s13027-025-00641-7.
Viart N, Renault A, Eon-Marchais S, Jiao Y, Fuhrmann L, El Houdigui S Breast Cancer Res. 2025; 27(1):36.
PMID: 40069712 PMC: 11899765. DOI: 10.1186/s13058-025-01988-w.
[Familial erythrocytosis type 2 due to VHL germline mutations: a case report and literature review].
Liu N, Pan L, Xiao Z, Xu Z Zhonghua Xue Ye Xue Za Zhi. 2025; 46(1):75-80.
PMID: 40059686 PMC: 11886440. DOI: 10.3760/cma.j.cn121090-20241011-00390.
Thirty Years of BRCA1: Mechanistic Insights and Their Impact on Mutation Carriers.
Moser S, Jonkers J Cancer Discov. 2025; 15(3):461-480.
PMID: 40025950 PMC: 11893084. DOI: 10.1158/2159-8290.CD-24-1326.